Tyme Technologies to Present at the 2020 Cross-Border Healthcare Webinar Series
(World News Science)

April 06, 2020 8:30 AM Download this Press Release PDF Format (opens in new window) NEW YORK--(BUSINESS WIRE)-- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsTM), announced that management will present at the 2020 Cross-Border Healthcare Webinar Series on Tuesday, April 7, 2020. The Company will present its corporate overview with a focus on: Growth opportunities driven by advances in the science of cancer metabolism, Recently launched pivotal trials in pancreatic cancer and a Phase II trial in...